학술논문
Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants
Document Type
Article
Author
Source
In: Journal of Medical Economics . (Journal of Medical Economics, 2023, 26(1):630-643)
Subject
Language
English
ISSN
1941837X
13696998
13696998